These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29945932)

  • 1. Dopamine Transporter Dynamics of
    Hong WC; Wasko MJ; Wilkinson DS; Hiranita T; Li L; Hayashi S; Snell DB; Madura JD; Surratt CK; Katz JL
    J Pharmacol Exp Ther; 2018 Sep; 366(3):527-540. PubMed ID: 29945932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change.
    Tanda G; Li SM; Mereu M; Thomas AM; Ebbs AL; Chun LE; Tronci V; Green JL; Zou MF; Kopajtic TA; Newman AH; Katz JL
    Psychopharmacology (Berl); 2013 Sep; 229(2):307-21. PubMed ID: 23612854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes.
    Jean B; Surratt CK; Madura JD
    J Mol Graph Model; 2017 Sep; 76():143-151. PubMed ID: 28734204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
    Katz JL; Agoston GE; Alling KL; Kline RH; Forster MJ; Woolverton WL; Kopajtic TA; Newman AH
    Psychopharmacology (Berl); 2001 Apr; 154(4):362-74. PubMed ID: 11349389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: studies conducted using intracerebral microdialysis and population pharmacodynamic modeling.
    Othman AA; Newman AH; Eddington ND
    J Pharmacol Exp Ther; 2007 Aug; 322(2):760-9. PubMed ID: 17519385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Substituted 3β-Aryltropane Cocaine Analogs Produce Atypical Effects without Inducing Inward-Facing Dopamine Transporter Conformations.
    Hong WC; Kopajtic TA; Xu L; Lomenzo SA; Jean B; Madura JD; Surratt CK; Trudell ML; Katz JL
    J Pharmacol Exp Ther; 2016 Mar; 356(3):624-34. PubMed ID: 26769919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. σ Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self-Administration.
    Hiranita T; Hong WC; Kopajtic T; Katz JL
    J Pharmacol Exp Ther; 2017 Jul; 362(1):2-13. PubMed ID: 28442581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the benztropine analog [
    Tomlinson MJ; Krout D; Pramod AB; Lever JR; Newman AH; Henry LK; Vaughan RA
    Neurochem Int; 2019 Feb; 123():34-45. PubMed ID: 30125594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.
    Loland CJ; Desai RI; Zou MF; Cao J; Grundt P; Gerstbrein K; Sitte HH; Newman AH; Katz JL; Gether U
    Mol Pharmacol; 2008 Mar; 73(3):813-23. PubMed ID: 17978168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors.
    Tanda G; Newman AH; Katz JL
    Adv Pharmacol; 2009; 57():253-89. PubMed ID: 20230764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter.
    Reith ME; Blough BE; Hong WC; Jones KT; Schmitt KC; Baumann MH; Partilla JS; Rothman RB; Katz JL
    Drug Alcohol Depend; 2015 Feb; 147():1-19. PubMed ID: 25548026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects.
    Li SM; Kopajtic TA; O'Callaghan MJ; Agoston GE; Cao J; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2011 Feb; 336(2):575-85. PubMed ID: 21088247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties.
    Schmitt KC; Zhen J; Kharkar P; Mishra M; Chen N; Dutta AK; Reith ME
    J Neurochem; 2008 Nov; 107(4):928-40. PubMed ID: 18786172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.
    Reith ME; Berfield JL; Wang LC; Ferrer JV; Javitch JA
    J Biol Chem; 2001 Aug; 276(31):29012-8. PubMed ID: 11395483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
    Katz JL; Kopajtic TA; Agoston GE; Newman AH
    J Pharmacol Exp Ther; 2004 May; 309(2):650-60. PubMed ID: 14755006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Isomeric Preference of an Atypical Dopamine Transporter Inhibitor Contributes to Its Selection of the Transporter Conformation.
    Abramyan AM; Stolzenberg S; Li Z; Loland CJ; Noé F; Shi L
    ACS Chem Neurosci; 2017 Aug; 8(8):1735-1746. PubMed ID: 28441487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel C-1 substituted cocaine analogs unlike cocaine or benztropine.
    Reith ME; Ali S; Hashim A; Sheikh IS; Theddu N; Gaddiraju NV; Mehrotra S; Schmitt KC; Murray TF; Sershen H; Unterwald EM; Davis FA
    J Pharmacol Exp Ther; 2012 Nov; 343(2):413-25. PubMed ID: 22895898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders.
    Zou MF; Cao J; Abramyan AM; Kopajtic T; Zanettini C; Guthrie DA; Rais R; Slusher BS; Shi L; Loland CJ; Newman AH
    J Med Chem; 2017 Dec; 60(24):10172-10187. PubMed ID: 29227643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics, brain distribution, and pharmacodynamics of 2nd generation dopamine transporter selective benztropine analogs developed as potential substitute therapeutics for treatment of cocaine abuse.
    Syed SA; Newman AH; Othman AA; Eddington ND
    J Pharm Sci; 2008 May; 97(5):1993-2007. PubMed ID: 17879975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.